Michele L. Basche, MD

NPI 1306820022ActiveIndividual· Internal Medicine, Hematology & Oncology· Denver, CO

Internal Medicine, Hematology & Oncology (MD) in Denver, Colorado, trained at University of California, San Francisco School of Medicine (class of 1996). In 2024 Medicare paid $2,169,478 for 705 patients, and Part D covered 1,949 of their prescriptions, 89% of them generic. Abbvie Inc. reported $18.74 in payments in 2025, mostly food and beverage.

Overview

NPI	1306820022
Status	Active
Entity type	Individual
Credential	MD
Sole proprietor	No
NPI issued	Dec 6, 2005
Last updated in NPPES	Feb 4, 2025
Certified by provider	Feb 4, 2025

Specialties and licenses

Taxonomy	Code	License	State
Internal Medicine, Hematology & Oncology Primary	207RH0003X	DR.0037127	CO

About license numbers in NPPES

Exclusion screening

List	Result	Details
HHS-OIG LEIE · Nov 10, 2026	No match	Checked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026	No match	—
New York OMIG · Nov 11, 2026	No match	—
Ohio Medicaid · Nov 11, 2026	No match	—
Pennsylvania Medicheck · Nov 11, 2026	No match	—
Washington HCA · Nov 11, 2026	No match	—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)	Enrolled Practitioner - Hematology/Oncology (CO)
Accepts assignment	Yes (participating)

Medicare services in 2024

Medicare patients	705
Services billed	118,222 across 167 procedure codes
Paid by Medicare	$2,169,478

Part D prescriptions in 2024

Prescriptions (claims)	1,949 · 3,817 30-day fills
Patients	335
Total drug cost	$1,450,645
Generic share	89% of claims

Medicare sources and data years

Education and affiliations

Medical school	University of California, San Francisco School of Medicine
Graduation year	1996
Medicare specialty	Hematology/Oncology
Telehealth	Offers telehealth